Affirma Biotech

Affirma Biotech is a preclinical-stage biotech company based in Barcelona, Spain, developing novel, orally available small molecule immunotherapeutics. The company focuses on host-directed therapies for the treatment of severe respiratory infections, including influenza and community-acquired pneumonia. Its approach aims to restore immune function in at-risk populations to reduce hospitalization and improve outcomes.